A Phase II Study to Evaluate JMKX000197 Injection Versus Cisplatin in the Treatment of Malignant Pleural Effusion

NCT07649369 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Pleural Effusions (Mpe)

Interventions

DRUG: JMKX000197
DRUG: Cisplatin

Sponsor

Shanghai Jeyou Pharmaceutical Co., Ltd.